Literature DB >> 9862094

CD4+ T cells orchestrate both amplification and deletion of CD8+ T cells.

L Frasca1, C Piazza, E Piccolella.   

Abstract

This review focuses on the role of CD4+ T cells in regulating immune responses, orchestrating both the amplification and deletion of immune cells, particularly CD8+ T cells. These two functions, which represent only an apparent contradiction, appear to be two faces of the same process of regulation. In fact, because the immune response, once activated, needs to be carefully controlled or switched off when the antigenic stimulus is eliminated, the immune system has developed several strategies either to regulate clonal amplification or to avoid useless expansion of activated cells. In particular, we have reported many data demonstrating that CD4+ T cells may be indicated as the regulatory element in the activation as well as the deletion of CD8+ T cells. New data are also reported on the ability of anergic CD4+ T cells to suppress CD8+ T-cell activation through induction of apoptosis, and on the need for CD8+ T cells for antigen recognition in inducing cell death in CD4+ T cells. Moreover, the central role of CD4+ T cells in the maintenance of peripheral tolerance has been widely described.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862094     DOI: 10.1615/critrevimmunol.v18.i6.50

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  8 in total

1.  Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells.

Authors:  Helen Y Wang; Tihui Fu; Gang Wang; Gang Zeng; Donna M Perry-Lalley; James C Yang; Nicholas P Restifo; Patrick Hwu; Rong-Fu Wang
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

2.  Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.

Authors:  Carsten Berges; Heinrich Haberstock; Dominik Fuchs; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel; Cord Naujokat
Journal:  Immunology       Date:  2008-01-23       Impact factor: 7.397

3.  T lymphocyte subset profile and serum alpha-1-antitrypsin in pathogenesis of chronic obstructive pulmonary disease.

Authors:  J Gupta; D Chattopadhaya; D P Bhadoria; M A Qadar Pasha; V K Gupta; M Kumar; R Dabur; V Yadav; G L Sharma
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

4.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

5.  Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.

Authors:  Man Kong; Hongmei Zhang; Xiaocui Cao; Xiaoli Mao; Zhongxin Lu
Journal:  Epidemiol Infect       Date:  2020-07-09       Impact factor: 2.451

Review 6.  A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host.

Authors:  Rinki Minakshi; Arif Tasleem Jan; Safikur Rahman; Jihoe Kim
Journal:  Front Cell Infect Microbiol       Date:  2020-10-16       Impact factor: 5.293

7.  Estimating the release of inflammatory factors and use of glucocorticoid therapy for COVID-19 patients with comorbidities.

Authors:  Dan Han; Chunfen Peng; Rui Meng; Jing Yao; Qiong Zhou; Yong Xiao; Hong Ma
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

8.  Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library.

Authors:  L-Y Luo; I Herrera; A Soosaipillai; E P Diamandis
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.